Notorious pharmaceutical entrepreneur Martin Shkreli was found guilty on two charges of securities fraud and one charge of conspiracy to commit conspiracy fraud.

A pediatric doctor in Alabama had to scramble to find a less expensive supply of a lifesaving drug to treat an infant who was suffering from a parasitic infection.   In Utah, a hospital has been forced to change the way it stocks a drug critical to treating heart patients after the cost skyrocketed from […]

NEW YORK – Turing Pharmaceuticals’ Martin Shkreli, once dubbed the most hated man in America, might not have a difficult time holding onto that title after telling a healthcare panel he should have raised the price of Daraprim even higher than the 5,000 percent increase he did. “I think I could have raised it higher […]

New York and Zug, Switzerland-based Turing Pharmaceuticals LLC announced yesterday a 50 percent cut in its prices for toxoplasmosis drug Daraprim.   Turing and its controversial chief executive officer Martin Shkreli became the focus of a national discussion of drug pricing in August after it acquired Daraprim from IMPAX Laboratories, Inc. (IPKL) for $55 million. […]

A U.S. Senate panel on Wednesday launched a bipartisan probe into pharmaceutical drug pricing, seeking documents from four drugmakers including Valeant Pharmaceuticals and Turing Pharmaceuticals, two companies embroiled in controversy over price hikes on lifesaving drugs.   The Senate’s Special Committee on Aging also requested information from Retrophin Inc and Rodelis Therapeutics, according to a […]

Martin Shkreli’s Turing Pharmaceuticals AG netted $90 million in Series A financing for use in advancing the company’s pipeline as well as possible M&A activity, the company announced this morning. New York-based Turing Pharmaceuticals is not sitting on the newly acquired funds. Today the company also announced that Turing acquired the U.S. rights to IMPAX […]